Authors:
TURNER JG
TAN J
CRUCIAN BE
SULLIVAN DM
BALLESTER OF
DALTON WS
YANG NS
BURKHOLDER JK
YU H
Citation: Jg. Turner et al., BROADENED CLINICAL UTILITY OF GENE GUN-MEDIATED, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR CDNA-BASED TUMOR-CELL VACCINES AS DEMONSTRATED WITH A MOUSE MYELOMA MODEL, Human gene therapy, 9(8), 1998, pp. 1121-1130
Authors:
MILLER TP
CHASE EM
DORR R
DALTON WS
LAM KS
SALMON SE
Citation: Tp. Miller et al., A PHASE I II TRIAL OF PACLITAXEL FOR NON-HODGKINS-LYMPHOMA FOLLOWED BY PACLITAXEL PLUS QUININE IN DRUG-RESISTANT DISEASE/, Anti-cancer drugs, 9(2), 1998, pp. 135-140
Authors:
TAYLOR CW
GREEN S
DALTON WS
MARTINO S
RECTOR D
INGLE JN
ROBERT NJ
BUDD GT
PARADELO JC
NATALE RB
BEARDEN JD
MAILLIARD JA
OSBORNE CK
Citation: Cw. Taylor et al., A MULTICENTER RANDOMIZED CLINICAL-TRIAL OF GOSERELIN VERSUS SURGICAL OVARIECTOMY IN PREMENOPAUSAL PATIENTS WITH RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - AN INTERGROUP STUDY, Journal of clinical oncology, 16(3), 1998, pp. 994-999
Citation: La. Hazlehurst et al., CHROMOSOME MEDIATED GENE-TRANSFER OF DRUG-RESISTANCE TO MITOXANTRONE, Anticancer research, 18(2A), 1998, pp. 1005-1010
Citation: Va. Kickhoefer et al., VAULTS ARE UP-REGULATED IN MULTIDRUG-RESISTANT CANCER CELL-LINES, The Journal of biological chemistry, 273(15), 1998, pp. 8971-8974
Authors:
LAMY T
LIU JH
LANDOWSKI TH
DALTON WS
LOUGHRAN TP
Citation: T. Lamy et al., DYSREGULATION OF FAS FAS LIGAND APOPTOTIC PATHWAY IN CD3+ LARGE GRANULAR LYMPHOCYTE (LGL) LEUKEMIA/, British Journal of Haematology, 102(1), 1998, pp. 278-278
Citation: Ws. Dalton, ALTERNATIVE (NON-P-GLYCOPROTEIN) MECHANISMS OF DRUG-RESISTANCE IN NON-HODGKINS-LYMPHOMA, Hematology/oncology clinics of North America, 11(5), 1997, pp. 975
Citation: Gs. Watts et al., METHYLATION OF DISCRETE REGIONS OF THE O-6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) CPG ISLAND IS ASSOCIATED WITH HETEROCHROMATINIZATION OF THE MGMT TRANSCRIPTION START SITE AND SILENCING OF THE GENE, Molecular and cellular biology, 17(9), 1997, pp. 5612-5619
Authors:
CHAN HSL
HADDAD G
ZHENG L
BRADLEY G
DALTON WS
LING V
Citation: Hsl. Chan et al., SENSITIVE IMMUNOFLUORESCENCE DETECTION OF THE EXPRESSION OF P-GLYCOPROTEIN IN MALIGNANT-CELLS, Cytometry, 29(1), 1997, pp. 65-75
Authors:
TAYLOR CW
DALTON WS
MOSLEY K
DORR RT
SALMON SE
Citation: Cw. Taylor et al., COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN, AND DEXAMETHASONE (CVAD) PLUS ORAL QUININE AND VERAPAMIL IN PATIENTS WITH ADVANCED BREAST-CANCER, Breast cancer research and treatment, 42(1), 1997, pp. 7-14
Citation: Mh. Oshiro et al., INFLUENCE OF INTERLEUKIN-6 ON RESPONSE TO FAS AND CHEMOTHERAPEUTIC DRUG-INDUCED APOPTOSIS IN MYELOMA CELL-LINES, Blood, 90(10), 1997, pp. 2203-2203
Citation: J. Damiano et al., UP-REGULATION OF INTEGRIN VLA-4 IS ASSOCIATED WITH LOW-LEVEL DRUG-RESISTANCE IN HUMAN MYELOMA CELLS, Blood, 90(10), 1997, pp. 2206-2206
Authors:
WANG H
JIANG ZG
WONG YW
DALTON WS
FUTSCHER BW
CHAN VTW
Citation: H. Wang et al., DECREASED CP-1 (NF-Y) ACTIVITY RESULTS IN TRANSCRIPTIONAL DOWN-REGULATION OF TOPOISOMERASE II-ALPHA IN A DOXORUBICIN-RESISTANT VARIANT OF HUMAN MULTIPLE-MYELOMA RPMI-8226, Biochemical and biophysical research communications, 237(2), 1997, pp. 217-224
Citation: Sm. Witherspoon et al., FLOW CYTOMETRIC ASSAY OF MODULATION OF P-GLYCOPROTEIN FUNCTION IN WHOLE-BLOOD BY THE MULTIDRUG-RESISTANCE INHIBITOR GG918, Clinical cancer research, 2(1), 1996, pp. 7-12
Authors:
ANDERSON JM
HEINDL LM
BAUMAN PA
LUDI CW
DALTON WS
CRESS AE
Citation: Jm. Anderson et al., CYTOKERATIN EXPRESSION RESULTS IN A DRUG-RESISTANT PHENOTYPE TO 6 DIFFERENT CHEMOTHERAPEUTIC-AGENTS, Clinical cancer research, 2(1), 1996, pp. 97-105
Authors:
LEHNERT M
DEGIULI R
KUNKE K
EMERSON S
DALTON WS
SALMON SE
Citation: M. Lehnert et al., SERUM CAN INHIBIT REVERSAL OF MULTIDRUG-RESISTANCE BY CHEMOSENSITIZERS, European journal of cancer, 32A(5), 1996, pp. 862-867
Citation: Se. Salmon et Ws. Dalton, RELEVANCE OF MULTIDRUG-RESISTANCE TO RHEUMATOID-ARTHRITIS - DEVELOPMENT OF A NEW THERAPEUTIC HYPOTHESIS, Journal of rheumatology, 23, 1996, pp. 97-101
Authors:
VOGLER WR
BERDEL WE
WINTON EF
GORDON DS
GELLER RB
HEFFNER LT
BROCHSTEIN JA
BEVERIDGE RA
DALTON WS
MILLER KB
LAZARUS HM
Citation: Wr. Vogler et al., LONG-TERM FOLLOW-UP OF EDELFOSINE PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA, Experimental hematology, 24(9), 1996, pp. 615-615